Moloney Securities Asset Management, LLC Clovis Oncology, Inc. Transaction History

Moloney Securities Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	SELL	$5.69 - $9.69 $62,590 - $106,590	-11,000 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$3.77 - $11.0 $41,470 - $121,000	11,000 New	11,000 $70,000
Q4 2019 Feb 06, 2020	SELL	$3.0 - $16.43 $180,000 - $985,800	-60,000 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$3.93 - $15.35 $235,800 - $921,000	60,000 New	60,000 $236,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.